GoodRx Holdings, Inc. GDRX Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by GoodRx Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.
The official record: GoodRx Holdings, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about GoodRx Holdings, Inc.'s additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GoodRx Holdings, Inc.'s additional paid-in capital?
- GoodRx Holdings, Inc. (GDRX) reported additional paid-in capital of $2.03B in Q1 2026.
- How has GoodRx Holdings, Inc.'s additional paid-in capital changed year-over-year?
- GoodRx Holdings, Inc.'s additional paid-in capital decreased by 2.5% year-over-year, from $2.08B to $2.03B.
- What is the long-term trend for GoodRx Holdings, Inc.'s additional paid-in capital?
- Over 5 years (2020 to 2025), GoodRx Holdings, Inc.'s additional paid-in capital has grown at a -0.7% compound annual growth rate (CAGR), from $2.1B to $2.03B.
- What does additional paid-in capital mean?
- This represents the excess amount paid by investors for common shares over their par value. It is a key component of shareholders' equity that captures the capital raised through equity offerings beyond the nominal value of the stock. It reflects the historical market premium at which the company has issued its shares.